Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I4FL
|
|||
| Former ID |
DIB001353
|
|||
| Drug Name |
N-1177-inh
|
|||
| Synonyms |
N-1177; PH-50; WIN-67722; Imaging agent (cancer), IMCOR; Imaging agent (cancer), Photogen; Imaging agent (cardiovascular), IMCOR; Imaging agent (cardiovascular), Photogen; N-1177-iv; N-1177-sq; N-1177-sq); Nanoparticle contrast agent (atherosclerosis), NanoScan Imaging; Nanoparticle contrast agent (cancer), NanoScan Imaging; Nanoparticle contrast agent (pulmonary tumor), NanoScan Imaging; N-1177 (inhaled, lung cancer), NanoScan Imaging; N-1177 (intravenous,atherosclerosis), NanoScan Imaging; N-1177 (subcutaneous,cancer), NanoScan Imaging
Click to Show/Hide
|
|||
| Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-9: 202.8, 208.9] | Discontinued in Phase 1 | [1] | |
| Company |
NanoScan Imaging LLC; NanoScan Imaging; IMCOR Pharmaceutical Co
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015744) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.